Broadening Eligibility Criteria and Diversity among Patients for Cancer Clinical Trials.
Kaur M, Frahm F, Lu Y, Ascha MS, Guadamuz JS, Dotan E, Gottesman AS, Leybovich BC, Sondhi A, Zhao Y, Meropol NJ, Royce TJ.
Kaur M, et al. Among authors: ascha ms.
NEJM Evid. 2024 Apr;3(4):EVIDoa2300236. doi: 10.1056/EVIDoa2300236. Epub 2024 Mar 26.
NEJM Evid. 2024.
PMID: 38771994